AR and neoplasm: Using datasets obtained with normal prostate tissues, prostate tumour samples and androgen-dependent cell lines such as VCaP and LNCaP cells (Fig. 6b, c and Supplementary Fig. S5), we identified a unique and major AR-binding peak in tumours and cell lines corresponding to AREs, located 6500 bp upstream of the FSCN1 transcriptional start site.